Skip to content

Mpx bioceutical aktienkurs

Mpx bioceutical aktienkurs

15/06/2017 · MPX Bioceutical Corporation Reports Financial Results for Its Fiscal First Quarter of 2019 Record Quarterly Revenues increased 224% to $14.5M TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Tag archive for MPX Bioceutical. Get The App. Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published. Latest MPX Bioceutical Share Price - Live MPX share price quotes, charts, profile, RNS & company financials for CNSX:MPX Get the detailed income statement for MPX Bioceutical Corp. (MPXEF). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue. The most sophisticated, fact-based financial stock information on MPX Bioceutical Corp (CSE: MPX) (OTCQX: MPXEF) extracted & parsed directly from SEC filings for free. 10/12/2018 · MPX Bioceutical News: auf dieser Seite finden Sie alle MPX Bioceutical News und Nachrichten zur MPX Bioceutical Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch MPX Bioceutical News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen

If you require additional information, please fill out this form and someone will contact you shortly. MPX Bioceutical Corporation. MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. Explore.

Get the latest MPX Bioceutical earnings report, revenues as well as upcoming MPX earnings dates, historical financial reports, news, analysis & more. 02/08/2018 · Das Unternehmen MPX Bioceutical . Die MPX Bioceutical-Aktie mit der Valor 39022045 bzw. der ISIN CA5534431021 . MPX Bioceutical ist ein Unternehmen aus Kanada. Im gleichen Bereich tätige Unternehmen sind z.B. MPX Bioceutical 01/02/2019 · NEW YORK and TORONTO, Jan. 31, 2019 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company"), (CSE: IAN, OTCQX: ITHUF) and MPX Bioceutical Corporation ("MPX") (CSE: MPX; OTC: MPXEF) jointly announce that the previously announced plan of arrangement (the "Arrangement") under the

25/04/2018 · MPXEF Stock MPX Bioceutical Corp. Live Analysis as of 04-25-2018. Today we take a look at the current stock price and stock chart for $MPXEF. If you are inte

30/11/2017 · TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (cse:MPX) MPXEF (the "Company" or "MPX") announced today that it has entered into an agreement with Echelon Wealth Partners Inc. ("Echelon"), as co-lead agent on behalf of a syndicate of agents including co-lead agent Canaccord 19/12/2017 · TORONTO, Dec. 19, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corp. (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to provide this corporate update concerning its previously announced brokered private placement (the “Placement”) of units (the “Units”), each Unit consisting of

Apex Business WordPress Theme | Designed by Crafthemes